Medios AG

Equities

ILM1

DE000A1MMCC8

Pharmaceuticals

Market Closed - Xetra 11:35:02 2024-07-16 EDT After market 15:50:01
17.22 EUR +0.58% Intraday chart for Medios AG 17.26 +0.23%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Medios AG(XTRA:ILM1) added to Germany SDAX (Total Return) Index CI
INDEX-MONITOR: Medios replaces Synlab in the SDax DP
Medios to Join Germany's SDAX Index Amid Synlab's Delisting MT
INDEX-MONITOR: Medios replaces Synlab in the SDax DP
Medios Founder Sells 15% Stake to Investment Company Luxempart MT
Medios AG announced that it has received funding from Luxempart S.A. CI
Luxempart S.A. acquired a 14.9% stake in Medios AG from Manfred Schneider. CI
Medios at two-month high after buy recommendation DP
Medios AG acquired Ceban B.V. from Bencis Capital Partners B.V. CI
Medios AG Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Transcript : Medios AG, Q1 2024 Earnings Call, May 07, 2024
Medios AG Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Medios AG Provides Earnings Guidance for the Year 2024 CI
Transcript : Medios AG, Ceban B.V. - M&A Call
Medios AG agreed to acquire Ceban B.V. from Bencis Capital Partners B.V. for ? 259 million. CI
Medios AG Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Transcript : Medios AG, Q3 2023 Earnings Call, Nov 14, 2023
Medios AG Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Transcript : Medios AG, H1 2023 Earnings Call, Aug 14, 2023
Medios to Sell Kölsche Blister Unit Amid Plan to Centralize Blister Business in Germany MT
Medios AG Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Transcript : Medios AG, Q1 2023 Earnings Call, May 11, 2023
Medios AG Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Medios AG Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Transcript : Medios AG, 2022 Earnings Call, Mar 30, 2023
Chart Medios AG
More charts
Medios AG, formerly Crevalis Capital AG, is a Germany-based company that is active in the pharmacy business. It wholesales, markets, distributes and produces various kinds of goods for pharmacies and other pharmaceutical companies. The Company also provides related services and is engaged in the acquisition and management of other companies from the pharmaceutical industry.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
17.12 EUR
Average target price
32 EUR
Spread / Average Target
+86.92%
Consensus
  1. Stock Market
  2. Equities
  3. ILM1 Stock
  4. News Medios AG
  5. Medios to Join Germany's SDAX Index Amid Synlab's Delisting